Literature DB >> 8718922

Plasma excitatory amino acids in autism.

H Moreno-Fuenmayor1, L Borjas, A Arrieta, V Valera, L Socorro-Candanoza.   

Abstract

Plasma amino acid levels were measured by high pressure liquid chromatography (HPLC) in fourteen autistic children, all below 10 years of age. Mean glutamic and aspartic acid valued were elevated (169 +/- 142 uM and 22.1 +/- 13 uM respectively) together with taurine (90.1 +/- 78.7 uM) (p > 0.1). All affected children had low levels of glutamine (241 +/- 166 uM; p < 0.01) and asparagine (22.9 +/- 12.9 uM; p < 0.01) as compared to normal values (585 +/- 25 and 59.2 +/- 4.2 uM respectively); eleven children had increased aspartic acid and eight children had high levels of glutamate; seven of these children had a concomitant increment of taurine. The increment of the three above mentioned compounds was observed at the same time only in five children. These findings demonstrate that abnormal plasmatic levels of neurotransmitter amino acids may be found in some autistic children. Increased glutamatemia may be dietary in origin or may arise endogenously for several reasons, among others, metabolic derrangements in glutamate metabolism perhaps involving vitamin B6, defects or blockage of the glutamate receptor at the neuronal compartment, or alterations in the function of the neurotransmitters transporters. Increments of taurine, an inhibitor, is likely compensatory and calcium dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718922

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  36 in total

1.  Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Authors:  Georgianne L Arnold; Susan L Hyman; Robert A Mooney; Russell S Kirby
Journal:  J Autism Dev Disord       Date:  2003-08

2.  Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo.

Authors:  Hrvoje Augustin; Yael Grosjean; Kaiyun Chen; Qi Sheng; David E Featherstone
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

3.  Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

Authors:  Rodney C Samaco; Amber Hogart; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-12-22       Impact factor: 6.150

Review 4.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

5.  Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

Authors:  Rabindra Tirouvanziam; Tetyana V Obukhanych; Julie Laval; Pavel A Aronov; Robin Libove; Arpita Goswami Banerjee; Karen J Parker; Ruth O'Hara; Leonard A Herzenberg; Leonore A Herzenberg; Antonio Y Hardan
Journal:  J Autism Dev Disord       Date:  2012-05

Review 6.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

Review 7.  Are therapeutic diets an emerging additional choice in autism spectrum disorder management?

Authors:  M Gogou; G Kolios
Journal:  World J Pediatr       Date:  2018-05-30       Impact factor: 2.764

Review 8.  The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Authors:  Donald C Rojas
Journal:  J Neural Transm (Vienna)       Date:  2014-04-22       Impact factor: 3.575

9.  A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Authors:  Antonio Y Hardan; Lawrence K Fung; Robin A Libove; Tetyana V Obukhanych; Surekha Nair; Leonore A Herzenberg; Thomas W Frazier; Rabindra Tirouvanziam
Journal:  Biol Psychiatry       Date:  2012-02-18       Impact factor: 13.382

10.  Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: a genetic association study on autism spectrum disorder.

Authors:  Shruti Dutta; Subha Das; Subhrangshu Guhathakurta; Barsha Sen; Swagata Sinha; Anindita Chatterjee; Sagarmoy Ghosh; Shabina Ahmed; Saurabh Ghosh; Rajamma Usha
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.